Displaying 1 - 50 of 225 results
Released Company Title Industry Topic
17 May 2021
18:00 CEST
THERANEXUS INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology Change in Capital
28 Apr 2021
18:00 CEST
THERANEXUS MISE À DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL 2020 20103010 Biotechnology Other subject
28 Apr 2021
18:00 CEST
THERANEXUS DOCUMENT D'ENREGISTREMENT UNIVERSEL 2020 20103010 Biotechnology Legal
09 Apr 2021
18:00 CEST
THERANEXUS INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology Change in Capital
07 Apr 2021
18:00 CEST
THERANEXUS 2020 FULL-YEAR RESULTS AND UPDATE ON THE PROGRESS OF MAIN PROGRAMS 20103010 Biotechnology Sales, Income, Commercial results
07 Apr 2021
18:00 CEST
THERANEXUS RÉSULTATS ANNUELS 2020 ET POINT SUR L'AVANCEMENT DE SES PRINCIPAUX PROGRAMMES 20103010 Biotechnology Sales, Income, Commercial results
07 Apr 2021
18:00 CEST
THERANEXUS RÉSULTATS ANNUELS 2020 ET POINT SUR L'AVANCEMENT DE SES PRINCIPAUX PROGRAMMES 20103010 Biotechnology Sales, Income, Commercial results
07 Apr 2021
18:00 CEST
THERANEXUS 2020 FULL-YEAR RESULTS AND UPDATE ON THE PROGRESS OF MAIN PROGRAMS 20103010 Biotechnology Sales, Income, Commercial results
07 Apr 2021
18:00 CEST
THERANEXUS 2020 FULL-YEAR RESULTS AND UPDATE ON THE PROGRESS OF MAIN PROGRAMS 20103010 Biotechnology Sales, Income, Commercial results
07 Apr 2021
18:00 CEST
THERANEXUS RÉSULTATS ANNUELS 2020 ET POINT SUR L'AVANCEMENT DE SES PRINCIPAUX PROGRAMMES 20103010 Biotechnology Sales, Income, Commercial results
10 Mar 2021
18:00 CET
THERANEXUS INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology Change in Capital
09 Mar 2021
18:00 CET
THERANEXUS THERANEXUS ÉTEND LES CAPACITÉS DE NEUROLEAD, SA PLATEFORME DE CRIBLAGE D'ACTIFS, A L'AUTOPHAGIE ET AUX MALADIES LYSOSOMALES NEUROLOGIQUES 20103010 Biotechnology Other subject
09 Mar 2021
18:00 CET
THERANEXUS THERANEXUS EXTENDS THE CAPABILITIES OF NEUROLEAD, ITS ACTIVE AGENT SCREENING PLATFORM, TO AUTOPHAGY AND NEUROLOGICAL LYSOSOMAL STORAGE DISORDERS 20103010 Biotechnology Other subject
17 Feb 2021
18:00 CET
THERANEXUS INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology Change in Capital
27 Jan 2021
18:00 CET
THERANEXUS INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology Change in Capital
19 Jan 2021
18:00 CET
THERANEXUS BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 2nd SEMESTRE 2020 20103010 Biotechnology Other subject
18 Jan 2021
18:05 CET
THERANEXUS THERANEXUS PRESENTS AN UPDATE ON THE PROGRESS OF ITS MAIN PROGRAMS AND ANNOUNCES ITS CASH POSITION AS OF 31 DECEMBER 2020 20103010 Biotechnology Other subject
18 Jan 2021
18:00 CET
THERANEXUS THERANEXUS FAIT UN POINT SUR l'AVANCEMENT DE SES PRINCIPAUX PROGRAMMES ET ANNONCE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2020 20103010 Biotechnology Other subject
28 Dec 2020
18:00 CET
THERANEXUS THERANEXUS PUBLIE SON AGENDA FINANCIER 2021 20103010 Biotechnology Other subject
28 Dec 2020
18:00 CET
THERANEXUS THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2021 20103010 Biotechnology Other subject
18 Dec 2020
08:00 CET
THERANEXUS THERANEXUS, LYON NEUROSCIENCE RESEARCH CENTER AND CERMEP ANNOUNCE THE CREATION AND FUNDING OF NEW JOINT PUBLIC/PRIVATE LABORATORY "NEUROIMAGING FOR DRUG DISCOVERY" (NI2D) 20103010 Biotechnology Other subject
18 Dec 2020
08:00 CET
THERANEXUS THERANEXUS, LE CENTRE DE RECHERCHE EN NEUROSCIENCES DE LYON ET LE CERMEP ANNONCENT LA CRÉATION ET LE FINANCEMENT D'UN NOUVEAU LABORATOIRE COMMUN PUBLIC/PRIVÉ " NEURO-IMAGING FOR DRUG DISCOVERY " (NI2D) 20103010 Biotechnology Other subject
19 Nov 2020
07:30 CET
THERANEXUS LA FOOD AND DRUG ADMINISTRATION (FDA) REND UN AVIS FAVORABLE AU PLAN DE DEVELOPPEMENT PRÉCLINIQUE DÉPOSÉ PAR THERANEXUS ET LA FONDATION BBDF 20103010 Biotechnology Other subject
19 Nov 2020
07:30 CET
THERANEXUS THE FOOD AND DRUG ADMINISTRATION (FDA) ISSUES A FAVORABLE OPINION ON THE PRECLINICAL DEVELOPMENT PLAN SUBMITTED BY THERANEXUS AND BBDF 20103010 Biotechnology Other subject
04 Nov 2020
18:00 CET
THERANEXUS PRESENTATION OF THE RESULTS OF THE PHASE IB CLINICAL STUDY OF THN201 FOR ALZHEIMER'S DISEASE AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE CONFERENCE (CTAD) 20103010 Biotechnology Other subject
04 Nov 2020
18:00 CET
THERANEXUS PRÉSENTATION DES RÉSULTATS DE L'ÉTUDE CLINIQUE DE PHASE 1b AVEC THN201 DANS LA MALADIE D'ALZHEIMER LORS DU CONGRES " CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) " 20103010 Biotechnology Other subject
21 Oct 2020
18:00 CEST
THERANEXUS THERANEXUS ET LA FONDATION BBDF OBTIENNENT LE STATUT DE " MÉDICAMENT ORPHELIN" EN EUROPE POUR BBDF-101 DANS LA MALADIE DE BATTEN 20103010 Biotechnology Other subject
21 Oct 2020
18:00 CEST
THERANEXUS THERANEXUS AND BBDF OBTAIN EUROPEAN "ORPHAN MEDICINAL PRODUCT" DESIGNATION FOR BBDF-101 IN BATTEN DISEASE 20103010 Biotechnology Other subject
15 Oct 2020
18:00 CEST
THERANEXUS THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 SEPTEMBRE 2020 20103010 Biotechnology Other subject
15 Oct 2020
18:00 CEST
THERANEXUS THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 SEPTEMBER 2020 20103010 Biotechnology Other subject
29 Sep 2020
18:00 CEST
THERANEXUS THERANEXUS ANNOUNCES ITS FIRST HALF 2020 RESULTS 20103010 Biotechnology Sales, Income, Commercial results
29 Sep 2020
18:00 CEST
THERANEXUS RESULTATS DU PREMIER SEMESTRE 2020 20103010 Biotechnology Sales, Income, Commercial results
29 Sep 2020
18:00 CEST
THERANEXUS THERANEXUS ANNOUNCES ITS FIRST HALF 2020 RESULTS 20103010 Biotechnology Sales, Income, Commercial results
29 Sep 2020
18:00 CEST
THERANEXUS RESULTATS DU PREMIER SEMESTRE 2020 20103010 Biotechnology Sales, Income, Commercial results
29 Sep 2020
18:00 CEST
THERANEXUS RESULTATS DU PREMIER SEMESTRE 2020 20103010 Biotechnology Sales, Income, Commercial results
29 Sep 2020
18:00 CEST
THERANEXUS THERANEXUS ANNOUNCES ITS FIRST HALF 2020 RESULTS 20103010 Biotechnology Sales, Income, Commercial results
09 Sep 2020
18:00 CEST
THERANEXUS THERANEXUS FAIT LE POINT SUR SON ACTUALITÉ SCIENTIFIQUE 20103010 Biotechnology Other subject
09 Sep 2020
18:00 CEST
THERANEXUS THERANEXUS PRESENTS ITS LATEST SCIENTIFIC NEWS 20103010 Biotechnology Other subject
07 Sep 2020
18:00 CEST
THERANEXUS INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology Change in Capital
07 Sep 2020
18:00 CEST
THERANEXUS DECLARATION OF TOTAL NUMBER OF SHARES AND VOTING RIGHTS 20103010 Biotechnology Change in Capital
11 Aug 2020
18:00 CEST
THERANEXUS THERANEXUS ET LA FONDATION BBDF OBTIENNENT LE STATUT DE " MÉDICAMENT ORPHELIN (ODD) " ET LA DÉSIGNATION DE " MALADIE RARE PEDIATRIQUE (RPDD)" PAR LA FOOD AND DRUG ADMINISTRATION (FDA) POUR BBDF-101 DANS LA MALADIE DE BATTEN 20103010 Biotechnology Other subject
11 Aug 2020
18:00 CEST
THERANEXUS THERANEXUS AND BBDF OBTAIN ORPHAN DRUG DESIGNATION (ODD) AND RARE PEDIATRIC DISEASE DESIGNATION (RPDD) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) FOR BBDF-101 FOR BATTEN DISEASE 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
11 Aug 2020
18:00 CEST
THERANEXUS THERANEXUS AND BBDF OBTAIN ORPHAN DRUG DESIGNATION (ODD) AND RARE PEDIATRIC DISEASE DESIGNATION (RPDD) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) FOR BBDF-101 FOR BATTEN DISEASE 20103010 Biotechnology Alliances and agreements, Mergers, Acquiqitions, Transferts
06 Aug 2020
18:00 CEST
THERANEXUS INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL 20103010 Biotechnology Change in Capital
06 Aug 2020
18:00 CEST
THERANEXUS DECLARATION OF TOTAL NUMBER OF SHARES AND VOTING RIGHTS 20103010 Biotechnology Change in Capital
30 Jul 2020
08:00 CEST
THERANEXUS THERANEXUS PRÉSENTERA LES RÉSULTATS DE THN102 DANS LA MALADIE DE PARKINSON A L'INTERNATIONAL CONGRESS OF PARKINSON'S DISEASE AND MOVEMENT DISORDERS (MDS) 2020 20103010 Biotechnology Other subject
30 Jul 2020
08:00 CEST
THERANEXUS THERANEXUS TO PRESENT THE RESULTS OF THN102 FOR PARKINSON'S DISEASE AT THE 2020 INTERNATIONAL CONGRESS OF PARKINSON'S DISEASE AND MOVEMENT DISORDERS 20103010 Biotechnology Other subject
20 Jul 2020
08:30 CEST
THERANEXUS BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 1er SEMESTRE 2020 20103010 Biotechnology Other subject
09 Jul 2020
08:30 CEST
THERANEXUS THERANEXUS ANNONCE SA POSITION DE TRÉSORERIE AU 30 JUIN 2020 ET LA MISE EN PLACE D'UNE LIGNE DE FINANCEMENT EN FONDS PROPRES 20103010 Biotechnology Sales, Income, Commercial results
09 Jul 2020
08:30 CEST
THERANEXUS THERANEXUS ANNOUNCES ITS CASH POSITION AS OF 30 JUNE 2020 AND IMPLEMENTATION OF A MANDATORY CONVERTIBLE BOND FACILITY 20103010 Biotechnology Sales, Income, Commercial results